According to data from the Ministry of Health, Social Services and Equality , the average cost per prescription grew by 1.4 percent between January 2016 and January 2017, despite a rate of increase of more than 2 percent in many months from last year. This moderate increase, coupled with a 3.2 percent increase in the number of prescriptions , translates into an increase in public pharmacy spending at pharmacy offices of 4.6 percent in that period. In turn, hospital spending fell 4.9 percent from January to November 2016, accumulating a year-on-year decline of 3.7 percent.
According to the forecast, these negative rates of change in the public hospital environment will be maintained in the coming months. These figures consolidate a situation of stability and control in the public pharmaceutical expenditure in a pharmaceutical and hospital markets, which favours the sustainability of the National Health System (SNS) and facilitates the patients’ access to the latest therapeutic innovations.